Definition of a Target for Immunotherapy and Results of the First Peptide Vaccination Study in Chronic Lymphocytic Leukemia

Immunotherapy for chronic lymphocytic le

Immunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitors

✍ Kharfan-Dabaja, M A; Wierda, W G; Cooper, L J N 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 439 KB

Subcutaneous Alemtuzumab in Fludarabine-

Subcutaneous Alemtuzumab in Fludarabine-Refractory Chronic Lymphocytic Leukemia: Clinical Results and Prognostic Marker Analyses From the CLL2H Study of the German Chronic Lymphocytic Leukemia Study Group

✍ Stilgenbauer, S.; Zenz, T.; Winkler, D.; Buhler, A.; Schlenk, R. F.; Groner, S.; 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 170 KB

Subcutaneous Alemtuzumab in Fludarabine-

Subcutaneous Alemtuzumab in Fludarabine-Refractory Chronic Lymphocytic Leukemia: Clinical Results and Prognostic Marker Analyses From the CLL2H Study of the German Chronic Lymphocytic Leukemia Study Group

✍ Stilgenbauer, S.; Zenz, T.; Winkler, D.; Buhler, A.; Schlenk, R. F.; Groner, S.; 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 170 KB

## Purpose The phase II CLL2H trial evaluated safety and efficacy of subcutaneous alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia (CLL). Clinical and biologic markers were evaluated for their impacts on outcome. ## Patients and Methods One hundred nine patients

Targeting cAMP in chronic lymphocytic le

Targeting cAMP in chronic lymphocytic leukemia: a pathway-dependent approach for the treatment of leukemia and lymphoma

✍ Murray, Fiona; Insel, Paul A 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 725 KB

Hematopoietic stem cells and progenitors

Hematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapy

✍ Yong, A S M; Keyvanfar, K; Eniafe, R; Savani, B N; Rezvani, K; Sloand, E M; Gold 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 575 KB

Lenalidomide and Rituximab for the Initi

Lenalidomide and Rituximab for the Initial Treatment of Patients With Chronic Lymphocytic Leukemia: A Multicenter Clinical-Translational Study From the Chronic Lymphocytic Leukemia Research Consortium

✍ James, D. F.; Werner, L.; Brown, J. R.; Wierda, W. G.; Barrientos, J. C.; Castro 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 576 KB